如何界定再灌注治疗的外界限
本文基于STAIR XI会议工作组讨论,探讨急性缺血性卒中再灌注治疗(静脉阿替普酶和血管内治疗)当前指南边界外的「外界限」。提出除统计显著性外需考虑最小临床重要差异,并纳入社会因素与生活质量评估疗效,建议补充平台试验、登记研究和大型实用性试验数据以提高泛化性。
要点
- 再灌注治疗指南基于随机试验,但指南外患者可能获益较小但仍具临床意义
- 界定外界限除统计显著性外应评估最小临床重要差异
- 平台试验、登记研究和大型实用性试验可补充随机对照试验数据
核心结论
- 再灌注治疗的外界限应基于统计显著性与最小临床重要差异共同界定,并纳入社会因素和生活质量考量。
- 医学界对获益的感知阈值可能与FDA批准所需阈值不同。
研究设计与样本
- STAIR XI会议工作组讨论,非系统综述或原始研究。
主要发现
- 当前指南基于随机试验中高度选择患者的显著治疗效应。
- 指南外患者可能获益较小但仍具临床意义。
- 平台试验、登记研究和大型实用性试验数据可补充随机对照试验以提高泛化性。
关键数值与推荐
- 探索再灌注治疗界限时应考虑最小临床重要差异,而不仅统计显著性。
临床怎么用
- 评估指南外患者再灌注治疗时,需综合统计显著性与最小临床重要差异,并考虑社会因素和生活质量。
- 可参考平台试验、登记研究和大型实用性试验数据辅助临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reperfusion therapy with intravenous alteplase and endovascular therapy are effective treatments for selected patients with acute ischemic stroke. Guidelines for treatment are based upon randomized trials demonstrating substantial treatment effects for highly selected patients based on time from stroke onset and imaging features. However, patients beyond the current established guidelines might benefit with lesser but still clinically significant treatment effects. The STAIR (Stroke Treatment Academic Industry Roundtable) XI meeting convened a workgroup to consider the "outer limits" of reperfusion therapy by defining the current boundaries, and exploring optimal parameters and methodology for determining the outer limits. In addition to statistical significance, the minimum clinically important difference should be considered in exploring the limits of reperfusion therapy. Societal factors and quality of life considerations should be incorporated into assessment of treatment efficacy. The threshold for perception of benefit in the medical community may differ from that necessary for the Food and Drug Administration approval. Data from alternative sources such as platform trials, registries and large pragmatic trials should supplement randomized controlled trials to improve generalizability to routine clinical practice. Further interactions between industry and academic centers should be encouraged.
引用
- Wechsler LR, Jadhav AP, Jovin TG, et al. How to Establish the Outer Limits of Reperfusion Therapy. Stroke. 2021. PMID: 34470484. doi:10.1161/STROKEAHA.121.035022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。